Comparison of Body Size, Morphomics, and Kidney Function as Covariates of High‐Dose Methotrexate Clearance in Obese Adults with Primary Central Nervous System Lymphoma-Reference-Cited by-同舟云学术

Comparison of Body Size, Morphomics, and Kidney Function as Covariates of High‐Dose Methotrexate Clearance in Obese Adults with Primary Central Nervous System Lymphoma

Published:2020-04 Issue:4 Volume:40 Page:308-319
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Pai Manjunath P.¹^ORCID,Debacker Kenneth C.¹,Derstine Brian²,Sullivan June²,Su Grace L.²³,Wang Stewart C.²

Affiliation:

1. Department of Clinical Pharmacy College of Pharmacy University of Michigan Ann Arbor Michigan

2. Department of Surgery Michigan Medicine University of Michigan Ann Arbor Michigan

3. Department of Medicine VA Ann Arbor Health System Ann Arbor Michigan

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2379

Reference44 articles.

1. Primary central nervous system lymphoma: A curable disease

2. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

3. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014

4. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015

5. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009–2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An interactive dose optimizer based on population pharmacokinetic study to guide dosing of methotrexate in Chinese patients with osteosarcoma;Cancer Chemotherapy and Pharmacology;2024-08-24

2. The Emerging Role and Clinical Applications of Morphomics in Diagnostic Imaging;Canadian Association of Radiologists Journal;2024-04-16

3. Understanding hemoglobin contribution to high-dose methotrexate disposition—population pharmacokinetics in pediatric patients with hematological malignancies;European Journal of Clinical Pharmacology;2024-02-12

4. External Evaluation of Population Pharmacokinetic Models for High‐Dose Methotrexate in Adult Patients with Hematological Tumors;The Journal of Clinical Pharmacology;2024-01-11

5. Outpatient administration of high-dose methotrexate in adults without drug monitoring – a case-control study of risk factors for acute kidney injury;Hematology, Transfusion and Cell Therapy;2023-12